Linatil Comp

Enalapril maleate, the active ingredient in Linatil Comp, is an ACE inhibitor presented as an oral tablet for oral use. It is combined with hydrochlorothiazide, a thiazide diuretic, to provide an additive antihypertensive effect by reducing vascular resistance and decreasing plasma volume in adults with elevated blood pressure.

GNH USA supplies Linatil Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, procurement teams and clinics worldwide.

Linatil Comp, a combined ACE inhibitor and thiazide diuretic, is indicated for the management of hypertension.

- Essential hypertension: lowers both systolic and diastolic blood pressure. - Diastolic hypertension: provides additional reduction in diastolic pressure. - Hypertension uncontrolled on monotherapy: adds complementary mechanisms to achieve target blood pressure.

Linatil Comp may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough: dry or persistent throat irritation. - Dizziness or light‑headedness: especially after the first doses. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Increased urination: due to diuretic effect. - Electrolyte disturbances: such as low potassium.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute renal impairment: sudden decrease in kidney function. - Hyperkalemia: elevated blood potassium levels. - Blood dyscrasias: rare blood cell abnormalities. - Severe dehydration: excessive fluid loss leading to electrolyte imbalance.

Before prescribing Linatil Comp, clinicians should consider several safety precautions.

- Renal function: assess baseline creatinine and monitor periodically. - Electrolyte balance: check serum potassium and sodium levels regularly. - Pregnancy: contraindicated (Category D) due to fetal risk. - Duplicate ACE inhibition: avoid using with other ACE inhibitors or ARBs. - Hypotension: monitor for symptomatic blood pressure drops, especially after the first dose. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Linatil Comp can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Aliskiren: concurrent use in diabetes or renal impairment can cause adverse renal effects. - Potassium‑sparing diuretics or supplements: risk of dangerous hyperkalemia. - NSAIDs: may blunt antihypertensive response and impair renal function. - Lithium: increased lithium concentrations leading to toxicity. - Angiotensin receptor blockers: combined ACE inhibition increases risk of angioedema and renal dysfunction.

Moderate Interactions (Monitor Closely): - Additional thiazide diuretics: additive blood pressure lowering and electrolyte loss. - Beta‑blockers: may enhance hypotensive effect. - Corticosteroids: can increase potassium loss. - Antidiabetic agents: may require dose adjustment due to improved glycemic control. - Anticoagulants: potential increase in bleeding risk.